Join us in celebrating our 25th anniversary

Psychotherapy as an epigenetic ‘drug’: psychiatric therapeutics target symptoms linked to malfunctioning brain circuits with psychotherapy as well as with drugs

Psychotherapy may be just as effective as psychopharmacology in treating psychiatric disorders. Psychotherapy focuses on psychodynamic and psychoanalytic prinicples while psychopharmacology is based on neurobiology. In the past, more emphasis was placed on psychopharmacology to treat psychiatric disorders. This article suggest that a psychotherapy could change the brain chemistry, eliciting the same results as drug […]

CBT/MET Therapy Helps Improve Symptoms in Comorbid MDD/AUD Adolescents

A recent, two-year acute phase trial published in Addictive Behaviors found both manual-based cognitive behavior therapy (CBT) and motivation enhancement therapy (MET) to be beneficial treatments for adolescents suffering from both major depressive disorder (MDD) and alcohol use disorder (AUD). This was the first controlled study to compare CBT/MET with fluoxetine or placebo versus naturalistic […]

The Biological Aspect of Depression

Dr. Aaron Beck discusses the neurological effects of depression and how Cognitive Behavior Therapy works in treating it. He also describes the biological aspect of the negative bias and how CBT can be used to reverse that bias. This video was taken at Beck Institute’s CBT for Children and Adolescents workshop. For more information, or […]

CBT for Depression

Dr. Aaron Beck explains the history of biological and psychological research on depression. He also discusses studies that looked at the likelihood of depression in people who experienced trauma during childhood. This video was taken at Beck Institute’s CBT for Children and Adolescents workshop, for more information, or to register for our next workshop visit: […]

Using Pupil Dilation to Screen Depressed Patients for Remission Likelihood with CBT Treatment

Research indicates that cognitive behavior therapy (CBT) is an effective treatment for up to 60% of patients with Major Depressive Disorder (MDD). However, some patients are more likely to remit than others, depending on the severity of the disorder. It is important and beneficial to patients, clinicians, and third-party payers alike, therefore, that scientists identify […]

What research is Dr. Beck presently involved in? (Students Ask Dr. Beck – Part SEVEN)

This is the seventh question from the Q&A portion of Beck Institute’s 3-Day CBT Workshop on Depression and Anxiety for students and post-doctoral fellows, held on August 15 – 17, 2011. In this video Dr. Aaron Beck discusses research he is presently involved in and/or leading at the University of Pennsylvania. Dr. Beck explains the […]